lies in close proximity to the hydrophobic binding site for electrophilic substrates (13) and it has been demonstrated that Two variant glutathione S-transferase cDNAs have been the val variant has altered specific activity and affinity for described at the GSTP1 locus, which differ by a single electrophilic substrates (14) . In order to establish whether these base pair (AϪG) substitution at nucleotide 313 of the sequences represent alleles at the GSTP1 locus, we designed GSTP1 cDNA. This results in an amino acid substitution a PCR assay to rapidly and simply detect their presence in the which alters the function of the enzyme. In this study, a population. Since GSTP1 is a major enzyme involved in the novel PCR assay has been developed which demonstrates inactivation of cigarette smoke carcinogens such as benzo [a] that these two variant cDNAs represent distinct GSTP1
pyrene diol epoxide and also other toxic cigarette smoke alleles (GSTP1a and GSTP1b). In a study of individuals constituents such as acrolein (1), we were interested to deterwith different forms of cancer, the GSTP1b allele is found mine whether this polymorphism was related to diseases to be strongly associated with bladder cancer and testicular associated with cigarette smoking such as certain types of cancer. In controls 6.5% of individuals were homozygous cancer and chronic obstructive pulmonary disease (COPD*). for the GSTP1b allele. In bladder cancer cases, this rose to 19.7% [n ⍧ 71, odds ratio 3.6 (1.4-9.2), P ⍧ 0.006] and in testicular cancer to 18.7% [n ⍧ 155, odds ratio 3.3 (1.5-Materials and methods 7.7), P ⍧ 0.002]. In addition, in prostate cancer a highly Introduction were taken from individuals attending chemotherapy, radiotherapy or surgical clinics at hospitals in Edinburgh over a 3-year period. In most cases, samples
The glutathione S-transferase supergene family consists of were supplied as EDTA treated blood. The colon cancer samples were supplied four gene subfamilies (GSTA, GSTM, GSTT and GSTP) which as DNA. Patient anonymity was maintained. Investigations were performed play a central role in the inactivation of toxic and carcinogenic with ethical agreement, and informed consent was obtained from each patient.
electrophiles (1). Certain genes within the GSTM and GSTT
Determination of genotype at the GSTP1 locus (GSTM1 and GSTT1) subfamilies exhibit deletion polymorph-A crude lysate was made from 100-200 ml whole blood (15) and 5-10 µl isms (2,3) which have been associated with cancer susceptibil-(corresponding to~50 ng DNA) was used as a template in a PCR reaction ity (2, 4, 5) . The risk to the individual carrying a variant of one with 200 ng each of primers P105F (5Ј ACC CCA GGG CTC TAT GGG AA 3Ј) and P105R (5Ј TGA GGG CAC AAG AAG CCC CT 3Ј), 1.5 mM MgCl 2 of these genes is estimated to be low, but the high frequency and 1 U Taq DNA polymerase (Promega, Southampton, UK) in a total volume in the population of some of these variants suggests that the of 40 µl. Initial denaturation was carried out at 95°C for 5 min. Cycling population attributable risk may be very high. The GSTP conditions were: primer annealing at 55°C for 30 s, polymerization at 72°C subfamily comprises a single gene (GSTP1) which is overfor 30 s and strand separation at 94°C for 30 s. Thirty cycles were carried expressed in both preneoplastic and neoplastic lesions in both out. A final polymerization step of 72°C for 5 min was carried out to complete the elongation processes. The PCR product (20 µl) was then digested with 5 rat and man (6) (7) (8) . In addition, the GSTP1 gene is inactivated U Alw261 (New England Biolabs, Hertfordshire, UK) in a total volume of by hypermethylation in the early stages of prostatic carcinogen-25 µl, and the products separated on a 3.5% agarose gel and subsequently esis (9) and is over-expressed in tumour cells made resistant stained with ethidium bromide (10 mg/ml) to visualize the bands.
to anticancer drugs (10) . The almost ubiquitous presence of
Direct sequencing of PCR products
Approximately 50 µl of PCR product was purified using the QIAquick PCR purification kit (Qiagen, Hilden, Germany) prior to the sequencing reactions. *Abbreviations: COPD, chronic obstructive pulmonary disease; OR, odds ratio.
The concentration of the PCR product was estimated by quantification on a 2% agarose gel. Approximately 250 ng of this product was used as a template in a double-stranded cycle sequencing reaction using the ds-DNA cycle sequencing system (Gibco-BRL, Paisley, UK) labelled with [γ 32 P]dATP and primer P105F. All reactions were carried out in an Omnigene thermal cycler (Hybaid, Middlesex, UK). Cycling conditions included an initial denaturation at 94°C for 5 min followed by 20 cycles of denaturation at 94°C for 30 s, primer annealing at 47°C for 60 s and polymerization at 72°C for 60 s. The reaction was completed by 10 cycles of denaturation at 94°C for 30 s and polymerization at 72°C for 60 s. Sequencing products were visualized on an 8% polyacrylamide sequencing gel with the inclusion of 40% formamide to enhance resolution, followed by autoradiography at Ϫ70°C for~14 h. Statistics Fig. 2 . A novel PCR assay to detect genetic polymorphism at the GSTP1 Odds ratios (OR) for the effect of genotype at the GSTP1 locus were calculated locus. (A) Diagrammatic representation of the assay design. A 176 bp according to the equation OR ϭ P1P4/P2P3 where P1 ϭ GSTP1b homozygotes region of genomic DNA flanking exon 5 was amplified using primers in the cancer cohort, P2 ϭ GSTP1a/GSTP1b or GSTP1a/GSTP1a genotypes P105F (5Ј ACC CCA GGG CTC TAT GGG AA 3Ј) and P105R (5Ј TGA in the cancer cohort, P3 ϭ GSTP1b homozygotes in the control cohort and GGG CAC AAG AAG CCC CT 3Ј). The PCR product was then digested P4 ϭ GSTP1a/GSTP1b or GSTP1a/GSTP1a genotypes in control cohort.
with Alw261. As a result of the AϪG difference at position 1578, an Frequencies for GSTP1b/GSTP1b homozygotes in cancer and control cohorts Alw261 is created in the GSTP1b allele. The consensus sequence were compared using χ 2 analysis for one degree of freedom or Fisher's exact corresponding to GSTP1a will not be cut, but the val105 sequence test where cell numbers were Ͻ5.
corresponding to GSTP1b will cleave to yield two fragments of 91 bp and 85 bp. The predicted pattern of bands is shown. (B) Identification of
Results and discussion
individuals homozygous for GSTP1a (ile105/ile105), heterozygous for GSTP1a/GSTP1b (ile105/val105) or homozygous for GSTP1b (val105/ In order to establish whether the published GSTP1 cDNA val105). The validity of the assay for the determination of these genotypes sequences represent alleles of GSTP1, we designed a PCR was determined by direct sequencing of PCR products as in Figure 3 .
assay to rapidly and simply detect their presence in the population. Gene specific PCR primers P105F and P105R ( Figure 1) were designed from the published sequence of associated with cancer susceptibility we studied the frequency of each genotype in different cancer groups. In a cohort of GSTP1 (16,17) to amplify a 176 bp region of the gene. The AϪG base pair substitution present in the GSTP1b allele bladder cancer patients a highly significant increase in the frequency of the GSTP1b/GSTP1b genotype was observed, allows each genotype to be identified with the diagnostic restriction enzyme Alw261 (Figure 2 ). Analysis of a random with an OR of 3.6 (95% CI ϭ 1.4-9.2, P ϭ 0.006). We should like to emphasize the need for a larger study of bladder cancer population did indeed demonstrate that GSTP1 was polymorphic at amino acid 105. The polymorphism was confirmed patients in order to substantiate these preliminary results. Interestingly, an increase was also observed in the proportion by direct sequence analysis of individuals predicted to be GSTP1a/GSTP1a, GSTP1a/GSTP1b and GSTP1b/GSTP1b of individuals with this haplotype in lung cancer patients with an OR of 1.9 (95% CI ϭ 0.7-4.8). However, this did not from the assay results (Figures 2 and 3) .
In a population of 155 healthy volunteers from the Edinburgh reach statistical significance (P ϭ 0.233). In a population with COPD (18), an increase in the proportion of individuals area, the frequencies of GSTP1a and GSTP1b were 0.72 and 0.28, respectively. A total of 6.5% of individuals were homozygous for the low activity GSTP1b allele was also observed. This finding is also interesting (although the P value homozygous for the low activity allele GSTP1b.
In order to establish whether the GSTP1 alleles were of 0.174 was not significant) in view of the known activity of Polymorphism of GSTP1 and cancer susceptibility GSTP1 in the inactivation of certain toxic components of A study of breast cancer and colon cancer did not show a cigarette smoke such as acrolein (1) . significant increase in susceptibility associated with the In further studies on other cancer types a highly significant GSTP1b allele compared to controls (P ϭ 0.77 and 0.82, increase in the proportion of individuals homozygous for the respectively). GSTP1b allele was found in both teratoma and seminoma
In prostatic cancer, although the numbers are small (n ϭ cancer samples with ORs of 3.4 (95% CI ϭ 1.4-8.4, P ϭ 36), there was a marked reduction in the frequency of GSTP1b 0.005) and 3.3 (95% CI ϭ 1.2-8.8, P ϭ 0.014), respectively, homozygotes, although this was not statistically significant and an OR of 3.3 (95% CI ϭ 1.5-7.7, P ϭ 0.002) when the (P ϭ 0.693). However, there was a highly significant reduction two tumour types are combined (Table I) . As the age of the in individuals homozygous for the GSTP1a alleles (P ϭ 0.008) control group was not determined, the change in GSTP1 allele and a significant increase in the proportion of heterozygotes frequency in testicular cancer could theoretically be explained (P ϭ 0.003). This is interesting because in almost all other by an age difference between the control and testicular cancer cancers the expression of GSTP1 in the tumour tissue is groups, and a link between the GSTP1b allele and longevity.
increased, whereas in prostatic cancer this enzyme appears to However, this is unlikely since there is no evidence to suggest be inactivated (9) . The aetiological factors implicated in that GSTP1 alleles affect longevity (R.C.Strange, personal prostatic carcinogenesis are also unclear, but hormone levels, communication). The causative agents for these diseases are a high dietary fat intake, exposure to sexually transmitted as yet unclear. To date, only cryptoorchidism, physical trauma, diseases and exposure to cadmium have all been suggested as testicular atrophy and exposure to sexually transmitted diseases risk factors (20) . No association has been reported between have been associated with increased risk of testicular cancers.
either tobacco or alcohol intake and prostatic cancer (20). It Other factors such as occupation, smoking, alcohol intake or is likely that genetic factors are involved, given the dramatic personal characteristics such as handedness have shown no fluctuations in risk of this particular cancer in different ethnic such association (19). As smoking has not been linked with groups. In particular, the risk of prostatic cancer is universally the risk of developing these tumours, further work will be high in black individuals originating from a wide variety of required to understand the molecular basis of our observation.
geographic locations (20). The fact that seven independent correlations have been made between GSTP1 genotype and cancer susceptibility raises the possibility that the correlations observed were due to chance. However, correcting the P values for this by multiplying by a factor of seven still results in highly significant results for bladder and testicular cancer (P ϭ 0.0036 and 0.014, respectively).
In summary, the above observations indicate that polymorphism at the GSTP1 locus may be an important factor in susceptibility to different types of cancer. The possession of a lower activity form of GSTP1-the GSTP1b allele-may be predicted to have severe consequences for an individual's cancer risk since GSTP1 is well known to have an important role in the detoxification of carcinogenic compounds such as an individual to cancer. Association of the GSTP1b allele with Odds ratios were calculated by comparison of random controls and cancer groups homozygous for the GSTP1b allele by methods described in the text.
Estimates of statistical significance were calculated by standard Chi-squared analysis for one degree of freedom, or by Fisher's exact test where cell numbers were Ͻ5. Statistically significant results are marked with *. N/A, odds ratios, chi-squared and P values were not applicable to these samples. COPD, chronic obstructive pulmonary disease.
